A two step, open-label, non-randomized, non-blinding retrospective and prospective observational clinical study to evaluate the effects of palmitoylethanolamide in patients with fibromyalgia.

Trial Profile

A two step, open-label, non-randomized, non-blinding retrospective and prospective observational clinical study to evaluate the effects of palmitoylethanolamide in patients with fibromyalgia.

Completed
Phase of Trial: Phase IV

Latest Information Update: 05 Jan 2016

At a glance

  • Drugs Palmitoylethanolamide (Primary) ; Duloxetine; Pregabalin
  • Indications Fibromyalgia
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Jan 2016 New trial record
    • 01 Dec 2015 Results published in the Pain and Therapy
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top